$1.63
-0.04-2.40%
Pre-Market: 4:03 PM EDT
Comments
Loading...
Aclaris Therapeutics Stock Guidance | NASDAQ:ACRS | Benzinga
Aclaris Therapeutics issues guidance on future EPS and revenue, giving investors insight into how much the company expects to earn in upcoming periods.
| Get Alert | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Aclaris Therapeutics Inc (ACRS) does not provide guidance data | ||||||||||||
FAQ
What is the most recent guidance for Aclaris Therapeutics (ACRS)?
There have been no specific sales or earnings guidance reported for Aclaris Therapeutics in recent months.
Browse guidance and forecast on all stocks.